There are 3164 resources available
Summary and Close
Presenter: Patrizia Giannatempo, Alison Birtle
Session: Johnson & Johnson - Optimising the personalisation of GU cancer care
Resources:
Webcast
LBA80 - Siremadlin (S) and ribociclib (R) in patients (pt) with advanced well-differentiated/dedifferentiated liposarcomas (WD/DD LPS) and other molecularly selected cancers: Final analysis of the MEGAMOST “Ribociclib/HDM201” basket study
Presenter: Mehdi Brahmi
Session: Mini oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
LBA18 - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or without brain metastases (BM): DESTINYBreast-12 primary results
Presenter: Nancy Lin
Session: Proffered paper session: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
LBA38 - Iparomlimab and tuvonralimab (QL1706) with bevacizumab and/or chemotherapy in first-line (1L) treatment of advanced hepatocellular carcinoma (aHCC): A randomized, open-label, phase II/III study (DUBHE-H-308)
Presenter: Shukui Qin
Session: Proffered paper session 1: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
988O - A phase I/II trial (LOKON003) evaluating tumor microenvironment (TME) gene engineering using a viral vector combined with atezolizumab in advanced malignant melanoma
Presenter: Gustav Ullenhag
Session: Proffered paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
603O - First clinical results from a phase I trial of PRT3789: A first-in-class intravenous SMARCA2 degrader, in patients with advanced solid tumors with a SMARCA4 mutation
Presenter: Robin Guo
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1925MO - Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC)
Presenter: Sophie Cousin
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Risk of gonadal toxicities with anticancer therapies with a focus on newer treatments
Presenter: Isabelle Demeestere
Session: Oncofertility: What every HCP involved in cancer care should know
Resources:
Slides
Webcast
Introduction
Presenter: Jayne Wood
Session: 9th ESMO Designated Centres of Integrated Oncology and Palliative Care session and awards: Specific considerations for integration of oncology and palliative care
Resources:
Slides
Webcast
Novel data in the field of immune checkpoint blockade for eTNBC
Presenter: Sara Tolaney
Session: The rapidly changing treatment landscape of early triple negative breast cancer
Resources:
Slides
Webcast